Stryker Corporation Stock

Equities

SYK

US8636671013

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 12:23:35 2024-07-03 pm EDT 5-day change 1st Jan Change
332.8 USD -0.44% Intraday chart for Stryker Corporation -2.36% +11.02%
Sales 2024 * 22.3B Sales 2025 * 24.02B Capitalization 127B
Net income 2024 * 3.89B Net income 2025 * 4.49B EV / Sales 2024 * 6.03 x
Net Debt 2024 * 7.21B Net Debt 2025 * 4.39B EV / Sales 2025 * 5.48 x
P/E ratio 2024 *
32.7 x
P/E ratio 2025 *
28.3 x
Employees 52,000
Yield 2024 *
0.99%
Yield 2025 *
1.08%
Free-Float 94.61%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.65%
1 week-1.55%
Current month-1.75%
1 month-1.99%
3 months-4.32%
6 months+12.85%
Current year+11.63%
More quotes
1 week
332.01
Extreme 332.01
344.94
1 month
332.01
Extreme 332.01
351.56
Current year
292.43
Extreme 292.43
361.41
1 year
249.98
Extreme 249.98
361.41
3 years
188.84
Extreme 188.84
361.41
5 years
124.54
Extreme 124.54
361.41
10 years
77.87
Extreme 77.87
361.41
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 11-04-24
Director of Finance/CFO 62 02-12-31
Chief Tech/Sci/R&D Officer - 14-12-31
Members of the board TitleAgeSince
Director/Board Member 80 73-12-31
Director/Board Member 66 18-05-01
Director/Board Member 89 77-01-31
More insiders
Date Price Change Volume
24-07-03 332.5 -0.55% 243 525
24-07-02 334.3 -0.65% 844,126
24-07-01 336.5 -1.10% 778,896
24-06-28 340.2 -0.09% 1,894,420
24-06-27 340.5 +0.01% 723,354

Delayed Quote Nyse, July 02, 2024 at 04:00 pm EDT

More quotes
Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
334.3 USD
Average target price
372.7 USD
Spread / Average Target
+11.50%
Consensus